Novome Biotechnologies and Genentech Enter into a Strategic Collaboration to Develop Targets Against Inflammatory Bowel Disease
November 10, 2021 08:32 ET
|
Novome Biotechnologies, Inc.
- Collaboration will leverage Novome’s GEMMs platform for colonizing the human gut with therapeutically engineered bacteria - - Novome to receive $15 million upfront payment; potential to receive up...